abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) at a glance
abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) is a small-cap Financial Services company. It trades at $20.66, with a P/E of 2.6, a 17857% profit margin and revenue decline of 60.8%. It pays a 12% dividend yield. Vestovix scores it 70/100 overall. Its strongest dimension is Value (99/100) and its weakest is Growth (12/100). Its volatility is roughly in line with the market.
- Price
- $20.66
- Market cap
- $515.4M
- P/E ratio
- 2.6
- Dividend yield
- 11.96%
- Beta
- 0.73
- 52-week range
- $13.88 to $22.67
Value
99
Growth
12
Income
97
Safety
80
Momentum
70
Other Financial Services stocks
See allJPM68
JPMorgan Chase & Co.
$356.60+0.74%
1.84% yield
V62
Visa Inc. Class A
$370.45+0.39%
0.81% yield
MA59
Mastercard Incorporated
$569.27+0.52%
0.67% yield
BAC70
Bank of America Corporation
$62.72+1.86%
2.00% yield
MS66
Morgan Stanley
$214.38-0.28%
1.87% yield
HSBC53
HSBC Holdings plc Sponsored ADR
$105.30+0.65%
4.03% yield
GS64
The Goldman Sachs Group, Inc.
$1,028.77-0.74%
1.60% yield
WFC67
Wells Fargo & Company
$90.31+1.88%
2.15% yield